Skin Problems and Treatments News, Features & Updates

October 8, 2026 — The FDA has approved Rhapsido (remibrutinib) for adults with symptomatic dermographism who remain symptomatic despite use of H1 antihistamines.

Learn how berotralstat works, who may benefit, possible side effects, and what to consider when deciding if this HAE treatment is right for you.

Learn who benefits from Takhzyro and how it helps prevent HAE attacks.

Learn from an expert in dermatomyositis about who may benefit most from treatment with brepocitinib, the first oral medicine approved for the condition.

Learn how ecallantide (Kalbitor) treats acute hereditary angioedema (HAE) attacks, how it works, and what to know about its use and safety.

Get the facts about donidalorsen (Dawnzera), a preventive treatment for hereditary angioedema (HAE).

Get the facts about sebetralstat (Ekterly), the first FDA-approved oral drug to treat acute hereditary angioedema (HAE) attacks.

April 23, 2026 — The FDA has approved Dupixent (dupilumab) as the first subcutaneous biologic in the U.S. for children ages 2-11 years with chronic spontaneous urticaria who have symptoms despite the use of histamine‑1 antihistamines.

March 24, 2026 — The FDA has approved Lynavoy (linerixibat) as a prescription pill to treat cholestatic pruritus – a severe, chronic, internal itch – in adults with primary biliary cholangitis (PBC).

March 16, 2026 — Cosentyx (secukinumab) is a fully human biologic medicine that targets and blocks interleukin‑17A (IL‑17A), a naturally occurring protein in the body that helps regulate the immune system and manage inflammation. The FDA has expanded the use of Cosentyx for treating children 12 and older with moderate-to-severe hidradenitis suppurativa (HS).

Dry skin can be an issue for anyone, but it doesn’t show up the same way on all skin tones. Find out which ingredients are most important for people with darker skin tones.

Hereditary angioedema causes intense swelling attacks, but doctors are making progress in treating this rare condition.

After a decades-long battle with health issues led to a hereditary angioedema diagnosis, a patient became an advocate for others with the ultra-rare disease.

Hereditary angioedema is a rare disease that causes intense swelling attacks. Here’s what a doctor who treats this condition wants you to know.

Experts have a new treatment option for chronic spontaneous urticaria (CSU) based on positive clinical trial results. Learn more about how remibrutinib works and who might benefit.

October 1, 2025 — Rhapsido (remibrutinib) is a new oral medicine approved to treat adults with chronic spontaneous urticaria (CSU). This alternative to injectable treatments blocks a protein in your body called Bruton’s tyrosine kinase (BTK), helping reduce symptoms.

September 17, 2025 — A recent FDA label update now allows Vyjuvek to be used from birth.

August 27, 2025 — New research links tattoos with cancer. Here's what scientists know about the potential connection, and their advice for you if you have a tattoo or you're thinking about getting inked.

August 22, 2025 — Dawnzera (donidalorsen) is a new medicine approved to help prevent attacks of a rare genetic swelling disorder known as hereditary angioedema (HAE) in people aged 12 or older.

Chronic spontaneous urticaria often triggers mental and emotional health issues. Learn about new ways – and meds – to make your life with CSU easier.

July 8, 2025 — The FDA has approved sebetralstat (sold as Ekterly), the first-ever pill for people 12 and older with hereditary angioedema, a rare genetic disorder that causes sudden and painful swelling that can sometimes be life-threatening.

June 27, 2025 — Classic, commonsense advice has evolved into upgraded protection and resources. Now you can do what the tick experts do.

June 23, 2025 — Up to 74% of UVA rays can sneak through standard windows, possibly aging or damaging your skin – even indoors.

June 18, 2025 — The FDA has approved a first-of-its-kind treatment for a rare genetic condition that causes frequent, unpredictable, and painful swelling in different parts of the body.

June 16, 2025 — With tickborne illnesses on the rise, experts are urging you to stay extra vigilant. Follow these six steps to protect yourself.

June 10, 2025 — A new report questions the safety and effectiveness of most sunscreens, but dermatologists say those concerns may be overblown and must be weighed against skin cancer risk.

April 30, 2025 — The FDA has approved a treatment called prademagene zamikeracel (sold as Zevaskyn), as a gene therapy for people with a rare genetic skin disorder known as recessive dystrophic epidermolysis bullosa (RDEB).

A dermatologist explains how new treatment dupilumab (Dupixent) is a game-changer if you have chronic spontaneous urticaria.

April 21, 2025 — The FDA has approved the popular drug Dupixent (generic name, dupilumab) for adults and kids 12 and up with chronic spontaneous urticaria (CSU), a long-lasting itchy skin condition, when regular allergy meds don't do the trick.

Hidradenitis suppurativa can take an emotional toll, and having people who understand is essential to managing this skin disorder.

Understand the racial disparities that affect people of color with hidradenitis suppurativa and how to ensure competent care.

A dermatologist shares expert insights into nemolizumab for atopic dermatitis. Learn about how well this new treatment works and who may benefit.

Psychodermatologists are doctors who are trained in both mental health and dermatology. Learn how they help with psoriasis, eczema, and more.

A dermatologist discusses nemolizumab (Nemluvio). Get the facts on this new treatment for prurigo nodularis: how well it works and who might benefit.

November 21, 2024 — The FDA has approved Bimzelx for adults with hidradenitis suppurativa (HS) or acne inversa, a type of chronic skin inflammation that affects about 1 in 100 people.

November 7, 2024 — The FDA has approved an antibiotic called minocycline for the treatment of rosacea in adults. The drug, which is taken orally, will be sold under the brand name Emrosi.

Hidradenitis suppurativa (HS) can make intimacy with your partner challenging. But you don’t have to let HS stand in the way of a loving connection.

July 19, 2024 — Tattoo ink tested from different manufacturers are contaminated with aerobic and anaerobic bacteria, including possibly pathogenic microorganisms, warn investigators.

February 21, 2024 — Experts say skin care is important, but teens are using too many products.

January 22, 2024 — Dairy, red meat, and carbohydrates can break down into compounds that may lead to skin problems like acne, dermatitis, rosacea and other common problems.

November 27, 2023 — Scientists have a promising new theory of what causes the sensation of itching, and their latest laboratory experiments point toward potentially effective treatments for people who have itchy skin due to eczema or dermatitis.

October 20, 2023 — A parasitic skin disease spread by sand flies that was once only linked to international travel is no longer considered an “imported” disease in the U.S.

September 5, 2023 — The CDC has issued an alert for cases of Vibrio vulnificus -- a rare flesh-eating bacteria that has killed 13 people in the Eastern United States this year.

August 21, 2023 — Flesh-eating bacteria have killed eight people along the Eastern seaboard, prompting health officials to urge people to take precautions around warm sea water or when cooking or eating shellfish.

August 1, 2023 — The skin and nervous system disease leprosy is now so common in central Florida that it is considered endemic in the southeastern United States, according to a new study published by the CDC.

June 23, 2023 — "It's a bit crude," Adele told the audience attending her Las Vegas residency as she shared that she has the fungal skin infection tinea cruris, commonly referred to as jock itch. "I never knew it existed."

June 16, 2023 — The FDA released the new guidance Monday aiming to reduce the use of pathogen-contaminated tattoo ink, which can cause stubborn infections that are especially hard to treat, dermatologists said.

Vitiligo presents certain challenges for people with darker skin. An expert discusses these and newer therapies on the horizon.

May 12, 2023 — After testing four popular body soaps, researchers at Virginia Tech found that three brands could potentially increase how attractive someone smells to mosquitoes, while one soap was less preferred by the disease-spreading insects.